Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mispacking of the F87 sidechain drives aggregation-promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer.
Journal: Protein science : a publication of the Protein Society
Published: April 04, 2024
Mispacking of the F87 sidechain drives aggregation-promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Journal: The New England journal of medicine
Published: February 21, 2024
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: July 28, 2023
Determining Binding Kinetics of Intrinsically Disordered Proteins by NMR Spectroscopy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 23, 2020
Automatic Seamline Determination for Urban Image Mosaicking Based on Road Probability Map from the D-LinkNet Neural Network.
Journal: Sensors (Basel, Switzerland)
Published: February 10, 2020
Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 21, 2018
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
Journal: Orphanet journal of rare diseases
Published: December 07, 2016
Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.
Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.
Journal: American journal of respiratory and critical care medicine
Published: August 06, 2016
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y.
Journal: Pediatric research
Published: January 23, 2015
Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome.
Journal: Clinical pharmacokinetics
Published: September 20, 2014
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial.
Journal: Clinical therapeutics
Published: September 02, 2014
Last Updated: 09/26/2026